Browse diseases

… and questionnaire assessing willingness to switch and baseline Asthma Control Test (ACT) score. Non-responders were followed up by te…

…isting of beclometasone/formoterol/glycopyrronium (BDP/FF/G) in asthma patients uncontrolled on a combination of an inhaled corticoste…

…lent in this cohort and could be under-recognised in the severe asthma population, including those on medium-dose ICS. The findings su…

… in response to biologics have been noted between patients with asthma and COPD, although they are often clinically difficult to diffe…

…onally regarding the over-reliance on SABA -only reliever among asthma patients which can lead to poor asthma control, increased risk …

…act of triple inhaled therapy versus dual therapy for achieving asthma remission is unknown.Methods We conducted a post-hoc analysis o…

…Introduction Remission is now an aspiration for asthma patients on biologics, although there is no agreed definition. …

…g developed as a potential treatment to reduce exacerbations of chronic respiratory diseases (Hohlfeld et al., 2025. Pulm. Pharmacol. Ther. 90). We have now…

…min D can modulate the expression of several miRNAs and reduces asthma exacerbations, but its molecular interaction with ICS remains u…

… indoors in winter. Primary outcomes for children’s health were asthma, airway problems, breathing difficulties, rhinitis symptoms, mo…

…underscores the potential of innovative technologies to enhance asthma and COPD management outside traditional healthcare settings.…

…ring an additional 10 items and 3 names for round 2. Near-fatal asthma (NFA) was the preferred name in round 3 (66.7%). The 22 items r…